Patent · US Active

Hybrid carriers for nucleic acid cargo

US11478552B2 · kind B2 · utility

9Cited by

2References

19Claims

0Family size

Assignee

CureVac AG · DE

Inventors

Patrick BAUMHOF · Dußlingen, DE
Carolin THIELE · Tübingen, DE
Joanna REJMAN · Tübingen, DE

Key dates

Filing date	Jun 9, 2017
Grant date	Oct 25, 2022
Priority date	—
Expiry date	Jul 22, 2039

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/0048
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A composition for the delivery of a nucleic acid compound is provided which comprises a cationic peptide or polymer and a lipidoid compound. The nucleic acid compound may be any chemically modified or unmodified DNA or RNA. The amount of the lipidoid in the composition is preferably low, relative to the cationic peptide or polymer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.